| abstract |
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R1, R2, R3, R4, Z, X and n are as defined herein, and wherein the compound comprises at least one 18 F moiety, are provided. Uses of such compounds for imaging diagnostics in cancer, including prostate cancer as well as methods and intermediates for preparing such compounds are also provided. |